Meet BioAge
Discover your Biological Age with BioAge, an innovative AI-Powered platform from Toku.
By utilizing retinal photography and advanced AI algorithms, BioAge provides you with an estimation of your biological age during a regular eye exam.
*BioAge has varying regulatory statuses depending on the region and is not yet cleared for sale in all markets. Please refer to the BioAge page or contact our support for more information and availability in your market.
Meet CLAiR™
Introducing an AI-Powered Platform for Cardiovascular Risk Assessment that uses retinal imaging to evaluate a person’s risk for cardiovascular events. This innovative solution provides a non-invasive, low-cost, and real-time alternative to current methods of calculating CVD risk.
*CLAIR has not yet been cleared for sale in any region.
Toku’s Vision
If you can see the future, you can change it
Our vision is clear: to ensure every person has access to early and accurate diagnosis of health conditions.
At the heart of our company is a personal story that drives our mission to make a difference in the world.
Toku’s CEO, Ehsan Vaghefi’s father’s experience with preventable blindness inspired a lifelong commitment to fighting preventable health outcomes.
At Toku, we believe that technology can play a key role in detecting health issues before it’s too late.
See how Toku is transforming healthcare through deep learning and AI
Instant Healthcare Diagnostics
Toku has developed multi-modal artificial intelligence platforms for instant healthcare diagnostics, personalized prognostics and general health risk assessments using retinal images to screen for preventable blindness and cardiovascular disease risk.
of the population should be monitored for diabetes, hypertension and macular degeneration
of cardiac events are preventable (2)
screening capacity increase (3)
reduction in cost of screening (3)
Click to View References & Sources
We take medical device quality seriously
At Toku, our commitment to quality is unwavering. As an ISO 13485 certified company, you can trust that our products are manufactured with the highest standards of quality and safety in mind.
ISO 13485 has been granted to Toku Eyes Ltd, a wholly-owned subsidiary of Toku Inc.
We are a world class interdisciplinary team
Our team includes Endocrinologists, Ophthalmologists, Optometrists, AI Specialists, global business and regulatory experts.
Associate Professor Ehsan Vaghefi
CEO – NZ
Dr David Squirrell
CMO – NZ
Mr Gerard Wallace
Executive Director – AU
Francesca Logan
CCO – NZ
Worldwide partners
